Basic Information
| LncRNA/CircRNA Name | LINC01296 |
| Synonyms | DUXAP9, LINC01296, FLJ39632, lncRNA-CTD903 |
| Region | GRCh38_14:19062316-19131167 |
| Ensemble | ENSG00000225210 |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Western blot, in vitro knockdown, RIP, etc. |
| Sample | bladder cancer tissues, human bladder cancer cell lines (RT4, T24, and 5637) |
| Expression Pattern | up-regulated |
| Function Description | The expression of LINC01296 was significantly higher in most cancer tissues than that in adjacent normal tissues,LINC01296 knockdown inhibited the proliferation, migration and progression of cell cycle of bladder cancer cells, and was involved in the regulation of epithelial-mesenchymal transition. |
| Pubmed ID | 30588032 |
| Year | 2019 |
| Title | Long noncoding RNA LINC01296 promotes cancer-cell proliferation and metastasis in urothelial carcinoma of the bladder |
External Links
| Links for LINC01296 | GenBank HGNC NONCODE |
| Links for bladder cancer | OMIM COSMIC |